Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Valproic acid
Drug ID BADD_D02329
Description Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a serendipitous discovery was made by George Carraz during his investigations into the anticonvulsant effects of khelline when he found that all of his samples, dissolved in valproic acid, exerted a similar degree of anticonvulsive activity. It first received approval on February 28, 1978 from the FDA under the trade name Depakene.[L6190] Since then, it has been investigated for neuroprotective, anti-manic, and anti-migraine effects. It is currently a compound of interest in the field of oncology for its anti-proliferative effects and is the subject of many clinical trials in a variety of cancer types.
Indications and Usage For treatment and management of seizure disorders, mania, and prophylactic treatment of migraine headache. In epileptics, valproic acid is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome.
Marketing Status Prescription; Discontinued
ATC Code N03AG01
DrugBank ID DB00313
KEGG ID D00399
MeSH ID D014635
PubChem ID 3121
TTD Drug ID D03LGY
NDC Product Code 0591-4012; 17856-0152; 63629-2454; 72189-267; 60432-621; 0121-4675; 72189-010; 43353-085; 17349-0005; 68108-0203; 71930-057; 69452-150; 62756-920; 66064-8001; 17856-0675; 11014-0054; 0121-1350; 0615-8205; 68094-701; 43353-107; 10888-8132; 11014-0050; 70518-0079; 63739-253; 70518-0730; 42291-844; 0832-0310; 23639-0003; 50383-792; 68094-193; 0121-0675; 0527-5250; 49452-8092; 63739-086; 68925-0002; 43353-279; 63629-7597; 60687-262
Synonyms Valproic Acid | 2-Propylpentanoic Acid | 2 Propylpentanoic Acid | Divalproex | Depakene | Convulsofin | Depakote | Dipropyl Acetate | Divalproex Sodium | Semisodium Valproate | Vupral | Valproic Acid, Sodium Salt (2:1) | Propylisopropylacetic Acid | Ergenyl | Magnesium Valproate | Valproate | Valproate Sodium | Sodium Valproate | Calcium Valproate | Valproate Calcium | Depakine
Chemical Information
Molecular Formula C8H16O2
CAS Registry Number 99-66-1
SMILES CCCC(CCC)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 1A2P05177Not AvailableNot Available
HepatotoxicityCytochrome P450 2E1P05181Not AvailableNot Available
HepatotoxicityCytochrome P450 2C9P11712T19244Not Available
HepatotoxicityCytochrome P450 2A6P11509T06455Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Alpers' disease03.18.01.002; 17.19.03.0040.000173%Not Available
Ectopic kidney20.01.06.006; 03.06.01.0090.000116%Not Available
Arachnodactyly15.11.07.018; 03.11.07.0180.000173%Not Available
Persistent left superior vena cava24.03.03.038; 03.07.04.0030.000886%Not Available
Tachyphrenia19.10.03.010; 17.03.03.0070.000886%Not Available
Prominent epicanthal folds06.06.04.022; 03.01.07.0030.000867%Not Available
Fine motor delay17.01.02.019; 19.22.01.0030.002214%Not Available
Congenital inguinal hernia03.04.07.005; 07.16.02.0030.001107%Not Available
Gross motor delay17.01.02.021; 19.22.01.0040.002879%Not Available
Acute lung injury22.01.03.0100.000231%Not Available
Brain midline shift17.11.01.0110.000443%Not Available
Coma scale abnormal13.07.03.0120.001772%Not Available
Pseudomonas test positive13.08.01.0130.000443%Not Available
Executive dysfunction19.21.02.0100.000664%Not Available
Motor developmental delay19.22.01.005; 17.01.02.0230.008636%Not Available
Herbal interaction08.06.03.0050.000231%Not Available
Benign rolandic epilepsy19.21.02.008; 17.12.03.0210.000443%Not Available
Idiopathic generalised epilepsy17.12.03.0260.000443%Not Available
Seizure cluster17.12.03.0290.000443%Not Available
Postural tremor17.01.06.0090.000443%Not Available
Craniofacial deformity15.11.02.005; 03.11.02.0050.001617%Not Available
Fine motor skill dysfunction17.01.02.0200.000664%Not Available
Selective eating disorder19.09.01.012; 14.03.02.0240.000443%Not Available
The 30th Page    First    Pre   30    Total 30 Pages